These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27436421)

  • 1. A novel RNA-guided RNA-targeting CRISPR tool.
    Zhang D; Li Z; Yan B; Li JF
    Sci China Life Sci; 2016 Aug; 59(8):854-6. PubMed ID: 27436421
    [No Abstract]   [Full Text] [Related]  

  • 2. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector.
    Abudayyeh OO; Gootenberg JS; Konermann S; Joung J; Slaymaker IM; Cox DB; Shmakov S; Makarova KS; Semenova E; Minakhin L; Severinov K; Regev A; Lander ES; Koonin EV; Zhang F
    Science; 2016 Aug; 353(6299):aaf5573. PubMed ID: 27256883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
    Wang W; Hou J; Zheng N; Wang X; Zhang J
    Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving CRISPR Genome Editing by Engineering Guide RNAs.
    Moon SB; Kim DY; Ko JH; Kim JS; Kim YS
    Trends Biotechnol; 2019 Aug; 37(8):870-881. PubMed ID: 30846198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGEN Editing of RNA and DNA: The Long and Winding Road from Catalytic RNAs to CRISPR to the Clinic.
    Sullenger BA
    Cell; 2020 May; 181(5):955-960. PubMed ID: 32470403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
    Yan F; Wang W; Zhang J
    Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiplexed CRISPR/Cas9 Genome Editing and Gene Regulation Using Csy4 in Saccharomyces cerevisiae.
    Ferreira R; Skrekas C; Nielsen J; David F
    ACS Synth Biol; 2018 Jan; 7(1):10-15. PubMed ID: 29161506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Csy4-based vector system enables conditional chimeric gene editing in zebrafish without interrupting embryogenesis.
    Wang J; Fei F; Berberoglu MA; Sun S; Wang L; Dong Z; Wang X
    J Mol Cell Biol; 2018 Dec; 10(6):586-588. PubMed ID: 30063795
    [No Abstract]   [Full Text] [Related]  

  • 9. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
    Donohoue PD; Barrangou R; May AP
    Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in CRISPR Base Editing: From A to RNA.
    Bjerke JN; Beardslee PC; McNaughton BR
    Biochemistry; 2018 Feb; 57(6):886-887. PubMed ID: 29373786
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Efficient Cpf1-Mediated Gene Targeting in Mice Following High Concentration Pronuclear Injection.
    Watkins-Chow DE; Varshney GK; Garrett LJ; Chen Z; Jimenez EA; Rivas C; Bishop KS; Sood R; Harper UL; Pavan WJ; Burgess SM
    G3 (Bethesda); 2017 Feb; 7(2):719-722. PubMed ID: 28040780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28.
    Smargon AA; Cox DBT; Pyzocha NK; Zheng K; Slaymaker IM; Gootenberg JS; Abudayyeh OA; Essletzbichler P; Shmakov S; Makarova KS; Koonin EV; Zhang F
    Mol Cell; 2017 Feb; 65(4):618-630.e7. PubMed ID: 28065598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's cut: DNA cleavage by CRISPR RNA-guided nucleases Cas9 and Cas12a.
    Swartjes T; Staals RHJ; van der Oost J
    Biochem Soc Trans; 2020 Feb; 48(1):207-219. PubMed ID: 31872209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
    Xiong X; Chen M; Lim WA; Zhao D; Qi LS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.